Skip to main navigation Skip to search Skip to main content

Glutamic acid decarboxylase antibodies in screening for autoimmune diabetes: influence of comorbidity, age, and sex on specificity and treshold values

  • Manou R. Batstra*
  • , Arianne van Driel
  • , Jacob S. Petersen
  • , Cees A. van Donselaar
  • , Maarten J. van Tol
  • , G. Jan Bruining
  • , Diederick E. Grobbee
  • , Thomas Dyrberg
  • , Henk-Jan Aanstoot
  • *Corresponding author for this work
  • Erasmus University Medical Centre
  • St. Clara's Hospital - Rotterdam
  • Leiden University Medical Centre
  • Novo Nordisk
  • IJsselland Ziekenhuis

Research output: Contribution to journal › Article › Academic › peer-review

17 Citations (Scopus)
53 Downloads (Pure)

Abstract

This study demonstrates that age- and sex-nondefined populations can be used for definition of reference values for glutamic acid decarboxylase (GAD65) antibodies and that comorbidity involving tissues that express GAD needs not be taken into account when screening for GAD antibodies. Because storage conditions may significantly affect the outcome of GAD antibody tests, these need to be monitored meticulously in collaborative studies.
Original languageEnglish
Pages (from-to)2269-2272
Number of pages4
JournalClinical Chemistry
Volume45
Issue number12
DOIs
Publication statusPublished - 1999

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research programs

  • EMC MM-01-54-01

Fingerprint

Dive into the research topics of 'Glutamic acid decarboxylase antibodies in screening for autoimmune diabetes: influence of comorbidity, age, and sex on specificity and treshold values'. Together they form a unique fingerprint.

Cite this